Related references
Note: Only part of the references are listed.Precision epidemiology for infectious disease control
Jason T. Ladner et al.
NATURE MEDICINE (2019)
Immunogenicity of Recombinant Adenovirus Type 5 Vector-Based Ebola Vaccine Expressing Glycoprotein from the 2014 Epidemic Strain in Mice
Ling Wang et al.
HUMAN GENE THERAPY (2018)
Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56
Margaret R. Duffy et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models
Qiang Guo et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Polysialic acid is a cellular receptor for human adenovirus 52
Annasara Lenman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses
Dennis Lapuente et al.
VACCINE (2018)
Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
Seo-Yeon Jung et al.
VACCINE (2018)
An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques
Yupeng Feng et al.
EMERGING MICROBES & INFECTIONS (2018)
The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly
Subrat Khanal et al.
BIOMEDICINES (2018)
Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses
Catherine M. Crosby et al.
JOURNAL OF VIROLOGY (2017)
Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane
Alessandra Vitelli et al.
EXPERT REVIEW OF VACCINES (2017)
Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for Therapy
Claudia Hagedorn et al.
HUMAN GENE THERAPY (2017)
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2017)
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
Kathleen A. McGuire et al.
MALARIA JOURNAL (2017)
Chimpanzee Adenovirus Vector Ebola Vaccine
Julie E. Ledgerwood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
S. B. Kennedy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery
Meike Kaulfuss et al.
RETROVIROLOGY (2017)
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™
Navin Venkatraman et al.
VACCINE (2017)
Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5
Franziska Jonsson et al.
VIRUS GENES (2017)
Open-label phase I clinical trial of Ad5-EBOV in Africans in China
Lihua Wu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines
Qianqian Li et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia
I. V. Dolzhikova et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
Jing-Xin Li et al.
LANCET GLOBAL HEALTH (2017)
HPV Vaccine utilization, Alberta 2008/09-2013/14 School year
Xianfang C. Liu et al.
BMC INFECTIOUS DISEASES (2016)
Viral vectors as vaccine platforms: from immunogenicity to impact
Katie J. Ewer et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013
L. Zhang et al.
EPIDEMIOLOGY AND INFECTION (2016)
Simian adenoviruses as vaccine vectors
Susan J. Morris et al.
FUTURE VIROLOGY (2016)
Safety and Immunogenicity of Novel Adenovirus Type 26-and Modified Vaccinia Ankara-Vectored Ebola Vaccines A Randomized Clinical Trial
Iain D. Milligan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
Muhammed O. Afolabi et al.
MOLECULAR THERAPY (2016)
Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions
Wei-Xiong Yang et al.
VACCINE (2016)
Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits
Azhar Choudhry et al.
VACCINE (2016)
Human CD8+T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice
Xiangming Li et al.
VACCINE (2016)
Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate
Chun Fang Shen et al.
VACCINE (2016)
A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors
Anitra L. Farrow et al.
VIRUSES-BASEL (2016)
Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43
Natalya Belousova et al.
ONCOTARGET (2016)
Adenoviral vector-based strategies against infectious disease and cancer
Chao Zhang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells
Karsten Eichholz et al.
PLOS PATHOGENS (2016)
Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation
Eun Kim et al.
EBIOMEDICINE (2016)
Epidemiology and Clinical Characteristics of Respiratory Infections Due to Adenovirus in Children Living in Milan, Italy, during 2013 and 2014
Susanna Esposito et al.
PLOS ONE (2016)
Early CD4+T Cell Responses Are Associated with Subsequent CD8+T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy
Edouard Lhomme et al.
PLOS ONE (2016)
Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon
Xiaobo Su et al.
PLOS ONE (2016)
A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine
Jairo Andres Fonseca et al.
PLOS ONE (2016)
Respiratory Infections in the US Military: Recent Experience and Control
Jose L. Sanchez et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Ebola virus vaccine: benefit and risks of adenovirus-based vectors
Franck J. D. Mennechet et al.
EXPERT REVIEW OF VACCINES (2015)
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
Xiaojuan Guo et al.
IMMUNOLOGY (2015)
Human mastadenovirus type 70: a novel, multiple recombinant species D mastadenovirus isolated from diarrhoeal faeces of a haematopoietic stem cell transplantation recipient
Elias Hage et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Multiple Cross-Species Transmission Events of Human Adenoviruses (HAdV) during Hominine Evolution
Eileen Hoppe et al.
MOLECULAR BIOLOGY AND EVOLUTION (2015)
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
Gloria Omosa-Manyonyi et al.
PLOS ONE (2015)
Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
Surender Khurana et al.
PLOS ONE (2015)
EBOLA VIRUS VACCINES Ebola vaccines based on adenovirus vectors and risk of HIV
Eric J. Kremer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
EBOLA VIRUS VACCINES Ebola vaccines based on adenovirus vectors and risk of HIV
Eric J. Kremer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Human Coagulation Factor X-Adenovirus Type 5 Complexes Poorly Stimulate an Innate Immune Response in Human Mononuclear Phagocytes
Karsten Eichholz et al.
JOURNAL OF VIROLOGY (2015)
Viral Co-Infections in Pediatric Patients Hospitalized with Lower Tract Acute Respiratory Infections
Miriam Cebey-Lopez et al.
PLOS ONE (2015)
Descriptive epidemiology of infectious gastrointestinal illnesses in Sydney, Australia, 2007-2010
Stephanie Fletcher et al.
WESTERN PACIFIC SURVEILLANCE AND RESPONSE (2015)
The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China
Li Jian et al.
ARCHIVES OF VIROLOGY (2014)
Adenovirus Species C Is Associated With Chronic Suppurative Lung Diseases in Children
Danielle F. Wurzel et al.
CLINICAL INFECTIOUS DISEASES (2014)
Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines
Jennifer M. Radin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Adenovirus Infections in Immunocompetent and Immunocompromised Patients
Thomas Lion
CLINICAL MICROBIOLOGY REVIEWS (2014)
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Ronald G. Crystal
HUMAN GENE THERAPY (2014)
Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals
Haitao Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Immune Activation with HIV Vaccines
Anthony S. Fauci et al.
SCIENCE (2014)
Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression
Matthew J. Johnson et al.
VACCINE (2014)
Protection of non-human primates against rabies with an adenovirus recombinant vaccine
Z. Q. Xiang et al.
VIROLOGY (2014)
IIIa deleted adenovirus as a single-cycle genome replicating vector
Catherine M. Crosby et al.
VIROLOGY (2014)
High prevalence and diversity of species D adenoviruses (HAdV-D) in human populations of four Sub-Saharan countries
Maude Pauly et al.
VIROLOGY JOURNAL (2014)
Vaccines within vaccines The use of adenovirus types 4 and 7 as influenza vaccine vectors
Eric A. Weaver
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Pre-existing immunity against Ad vectors Humoral, cellular, and innate response, what's important?
Hugues Fausther-Bovendo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China
Xiang Wang et al.
EMERGING MICROBES & INFECTIONS (2014)
HUMAN ADENOVIRUS: VIRAL PATHOGEN WITH INCREASING IMPORTANCE
B. Ghebremedhin
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2014)
A Single Intraduodenal Administration of Human Adenovirus 40 Vaccine Effectively Prevents Anaphylactic Shock
Satoshi Yamasaki et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
Dan H. Barouch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults
Shujun Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
Marc Gurwith et al.
LANCET INFECTIOUS DISEASES (2013)
Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines
Eric A. Weaver et al.
PLOS ONE (2013)
A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age
Alphonse Ouedraogo et al.
PLOS ONE (2013)
A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
Fiona Smaill et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in US military recruits
Robert A. Kuschner et al.
VACCINE (2013)
Temporal changes in respiratory adenovirus serotypes circulating in the greater Toronto area, Ontario, during December 2008 to April 2010
Kaniza Zahra Abbas et al.
VIROLOGY JOURNAL (2013)
Enhanced growth of recombinant human Adenovirus type 41 (HAdV-41) carrying ADP gene
Zhuo-Zhuang Lu et al.
VIRUS RESEARCH (2013)
Molecular evolution of human adenoviruses
Christopher M. Robinson et al.
SCIENTIFIC REPORTS (2013)
Identification and typing of respiratory adenoviruses in Guangzhou, Southern China using a rapid and simple method
Guiyuan Han et al.
VIROLOGICA SINICA (2013)
Rare serotype adenoviral vectors for HIV vaccine development
Nelson L. Michael
JOURNAL OF CLINICAL INVESTIGATION (2012)
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
Nicole Frahm et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China
Bin Yu et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
The Number of Toll-Like Receptor 9-Agonist Motifs in the Adenovirus Genome Correlates with Induction of Dendritic Cell Maturation by Adenovirus Immune Complexes
Matthieu Perreau et al.
JOURNAL OF VIROLOGY (2012)
Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin
Jeff Alexander et al.
PLOS ONE (2012)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Analysis of Human Adenovirus Type 19 Associated with Epidemic Keratoconjunctivitis and its Reclassification as Adenovirus Type 64
Xiaohong Zhou et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
High Titers of Pre-existing Adenovirus Serotype-Specific Neutralizing Antibodies in the Host Predict Viral Reactivation After Allogeneic Stem Cell Transplantation in Children
Louise A. Veltrop-Duits et al.
CLINICAL INFECTIOUS DISEASES (2011)
The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis
Emma C. Nilsson et al.
NATURE MEDICINE (2011)
The Burden of Rotavirus Disease in Denmark 2009-2010
Thea K. Fischer et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Dan H. Barouch et al.
VACCINE (2011)
Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28
Christoph A. Kahl et al.
VACCINE (2010)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
T. Christopher Mast et al.
VACCINE (2010)
Adenovirus interactions with CD46 on transgenic mouse erythrocytes
Emma K. Andersson et al.
VIROLOGY (2010)
Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys
Jonatan Ersching et al.
VIROLOGY (2010)
Unique sequence features of the Human Adenovirus 31 complete genomic sequence are conserved in clinical isolates
Soeren Hofmayer et al.
BMC GENOMICS (2009)
Novel recombinant adenovirus type 41 vector and its biological properties
Zhuo-Zhuang Lu et al.
JOURNAL OF GENE MEDICINE (2009)
Evidence of Molecular Evolution Driven by Recombination Events Influencing Tropism in a Novel Human Adenovirus that Causes Epidemic Keratoconjunctivitis
Michael P. Walsh et al.
PLOS ONE (2009)
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1
Adel Benlahrech et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector
Qiwei Zhang et al.
VACCINE (2009)
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
M. Dudareva et al.
VACCINE (2009)
The Cell Adhesion Molecule CAR'' and Sialic Acid on Human Erythrocytes Influence Adenovirus In Vivo Biodistribution
Elena Seiradake et al.
PLOS PATHOGENS (2009)
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus
Kanakatte Raviprakash et al.
JOURNAL OF VIROLOGY (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
Maria A. Croyle et al.
PLOS ONE (2008)
A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults
Arthur Lyons et al.
VACCINE (2008)
Gene therapy clinical trials worldwide to 2007 - an update
Michael L. Edelstein et al.
JOURNAL OF GENE MEDICINE (2007)
New adenovirus species found in a patient presenting with gastroenteritis
Morris Saffold Jones et al.
JOURNAL OF VIROLOGY (2007)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: Implications for clinical efficacy
Matthieu Perreau et al.
JOURNAL OF VIROLOGY (2007)
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
Franck Lemiale et al.
VACCINE (2007)
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity
Anna R. Thorner et al.
JOURNAL OF VIROLOGY (2006)
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa
Zhiquan Xiang et al.
EMERGING INFECTIOUS DISEASES (2006)
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity
Angelique A. C. Lemckert et al.
JOURNAL OF GENERAL VIROLOGY (2006)
A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques
S Capone et al.
JOURNAL OF VIROLOGY (2006)
Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus
M Perreau et al.
JOURNAL OF VIROLOGY (2005)
Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: Phylogenetic, taxonomic, and clinical implications
K Ebner et al.
JOURNAL OF VIROLOGY (2005)
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity
AAC Lemckert et al.
JOURNAL OF VIROLOGY (2005)
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein
SM Sumida et al.
JOURNAL OF IMMUNOLOGY (2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
KR Van Kampen et al.
VACCINE (2005)
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene:: Application in epidemiologic studies and in the design of adenovector vaccines
M Aste-Amézaga et al.
HUMAN GENE THERAPY (2004)
Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: Low seroprevalence and non-cross-reactivity with Ad5
L Holterman et al.
JOURNAL OF VIROLOGY (2004)
A two decade survey of respiratory adenovirus in Taiwan: The reemergence of adenovirus types 7 and 4
KH Lin et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
S Kostense et al.
AIDS (2004)
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
DH Barouch et al.
JOURNAL OF IMMUNOLOGY (2004)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination:: Efficient human cell infection and bypass of preexisting adenovirus immunity
R Vogels et al.
JOURNAL OF VIROLOGY (2003)
Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: Addressing preexisting immunity to vaccine and gene therapy vectors
MC Sprangers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes
CT Garnett et al.
JOURNAL OF VIROLOGY (2002)
Molecular and epidemiological analyses of human adenovirus type 7 strains isolated from the 1995 nationwide outbreak in Japan
M Noda et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer
M Hillgenberg et al.
JOURNAL OF VIROLOGY (2001)
Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration
A Vos et al.
JOURNAL OF GENERAL VIROLOGY (2001)
The epidemiology of adenovirus infections in Greater Manchester, UK 1982-96
RJ Cooper et al.
EPIDEMIOLOGY AND INFECTION (2000)
Share Paper
